Thank You

Thanks to everyone who made this year’s Trans-Pacific Health Sciences Dialogue such a great success. We are grateful for the contributions of our attendees, speakers and sponsors that made this such a special event.

See you next year in Boston

Take a look at some photos from the 2014 Trans-Pacific Health Sciences Dialogue!

Day 1 PhotosDay 2 Photos

About the Conference

The Trans-Pacific Health Sciences Dialogue is a C-level meeting for biopharmaceutical industry executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America. This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.

Sponsors

Sponsors_200px

Supporters

Supporters_200px

Who Should Attend

WhoShouldAttend

The Trans-Pacific Health Sciences Dialogue is an invitation-only event for Asian and North American senior biopharmaceutical executives, KOLs and select professional industry advisors, service providers and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment. To request an invitation, please contact Lawrence Joseph.

Industry News from BioCentury

  • Venture tracksFrazier Healthcare promoted Ben Magnano to general partner from senior associate. He is a member of Frazier's growth buyout team, which invests in healthcare services, pharmaceutical services, healthcare IT, products, supplies and specialty distribution.
Read more

Industry News from PharmAsia

  • Big Biologics Bet: China’s Innovent Gets $100m FinancingA record-breaking private financing for a Chinese biotech has seen bets placed on Suzhou-based Innovent Bio, which has 10 monoclonal antibodies including four biosimilars in its pipeline.<img src="//feeds.feedburner.com/~r/_PharmAsiaNews/~4/doWczV5C--8" height="1" width="1" alt="" />
Read more

Upcoming Supporter Events

Print

Life Science Future
October 13-14, 2014
Sheraton Downtown Hotel
Philadelphia, PA

Read more